Luoxin Aurovitas Pharma Chengdu

Luoxin Aurovitas Pharma Chengdu is a joint venture established between Shandong Luoxin Pharmaceutical Group and Aurovitas (a subsidiary of Aurobindo Pharma). The company focuses on the research, development, and high-standard manufacturing of pharmaceutical products, particularly in the fields of digestive health, respiratory medicine, and anti-infectives. Operating out of Chengdu, China, the facility is designed to meet international GMP standards, including those of the US FDA and EU, to facilitate the export of high-quality generic and innovative medicines. Its portfolio leverages Luoxin's strong domestic commercial presence and Aurobindo's global supply chain and formulation expertise.